Published • loading... • Updated
Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development
Summary by psychedelicalpha.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development
Dr. Husseini Manji’s affiliations are quite the laundry list: a professor of psychiatry at the University of Oxford with adjunct and visiting positions at Yale and Duke, as well as serving as co-chair of the UK government’s mental health mission. But it’s his earlier work as a pioneer in the development of rapid-acting antidepressants that concerns this interview, with Manji’s role in esketamine’s… Source
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
